Game Plan Financial Advisors’s Rein Therapeutics RNTX Stock Holding History
Bought
Maintained
Sold
Other funds holding RNTX
BCM
VC
UOTTAIMCU
PM
CCC
SPC
SM
KL
Game Plan Financial Advisors's RNTX Position: Q2 2025 in Review
Game Plan Financial Advisors sold out of Rein Therapeutics (RNTX) in Q2 2025, closing a stake of 25 shares — an estimated $44 sold.
Game Plan Financial Advisors first reported a position in RNTX in Q4 2019 and held it in 17 quarters. The position peaked at $130K in Q3 2021. 36 funds tracked by Wall St. Rank hold RNTX as of Q2 2025.
- Game Plan Financial Advisors reported no remaining Rein Therapeutics position as of Q2 2025 after selling out during the quarter.
- Game Plan Financial Advisors sold 25 Rein Therapeutics shares in Q2 2025, an estimated $44.
- Game Plan Financial Advisors first reported a position in Rein Therapeutics in Q4 2019 and held it in 17 quarters.
- Game Plan Financial Advisors's Rein Therapeutics position peaked at $130K in Q3 2021.
- 36 funds tracked by Wall St. Rank held Rein Therapeutics as of Q2 2025.
Based on Game Plan Financial Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.